Physician profile
Tyler Radkey
NPI 1265631824
$1,138.96
in general payments reported to CMS, 2019-2025
4 companies · $1,013 in 2025
The $1,013 reported for 2025 was more than what 95% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.84 · 2021: $28.79 · 2022: $78.99 · 2025: $1,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,013.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hu-Friedy Mfg. Co., LLC | $1,013.34 | 2025 | Hu-Friedy Power Air & Piezo Unit |
| Align Technology, INC. | $72.82 | 2020-2022 | |
| Dentsply Sirona INC | $40.44 | 2021-2022 | |
| Voco America INC. | $12.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Radkey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.